✦ LIBER ✦

Downbeating Nystagmus and Muscle Spasms in a Patient with Glutamic-acid Decarboxylase Antibodies

✍ Scribed by Beau M. Ances; Josep O. Dalmau; Jean Tsai; M. Josh Hasbani; Steven L. Galetta

Book ID: 116200303
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 337 KB
Volume: 140
Category: Article
ISSN: 0002-9394
DOI: 10.1016/j.ajo.2004.12.052

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antinuclear antibodies and glutamic acid

Antinuclear antibodies and glutamic acid decarboxylase antibodies in children with refractory epilepsy

✍ Abd El-Aziz, Sahar A.; El-Serogy, Hesham 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 487 KB

Clinical significance of glutamic acid d

Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy

✍ Suvi Liimatainen; Maria Peltola; Lidia Sabater; Mahdi Fallah; Elham Kharazmi; An 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 179 KB

Anticardiolipin, glutamic acid decarboxy

Anticardiolipin, glutamic acid decarboxylase, and antinuclear antibodies in epileptic patients

✍ A. Verrotti; R. Greco; E. Altobelli; G. Latini; G. Morgese; F. Chiarelli 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 47 KB

Glutamic acid decarboxylase antibodies,

Glutamic acid decarboxylase antibodies, autonomic nerve antibodies and autonomic neuropathy in diabetic patients

✍ G. Sundkvist; L. A. Velloso; O. Kämpe; S. L. Rabinowe; S. A. Ivarsson; B. Lilja; 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 859 KB

Epilepsy and cerebellar ataxia associate

Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies

✍ Vulliemoz, S; Vanini, G; Truffert, A; Chizzolini, C; Seeck, M 📂 Article 📅 2007 🏛 BMJ Publishing Group 🌐 English ⚖ 410 KB

Elimination of islet cell antibodies and

Elimination of islet cell antibodies and glutamic acid decarboxylase antibodies II in a patient with newly diagnosed insulin-dependent diabetes mellitus

✍ W. O. Richter; M. G. Donner; P. Schwandt 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Islet cell antibodies and glutamic acid decarboxylase II (GAD II) antibodies have been discussed in the autoimmune pathogenesis of insulin-dependent diabetes mellitus (IDDM). Hence, immunosuppressants, intravenous immunoglobulins, and plasmapheresis have been used in an effort to modulate autoimmune